CervoMed to Participate in the Canaccord Genuity 45th Annual Growth Conference

BOSTON, Aug. 05, 2025 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders, today announced that Company management will participate in a fireside chat and one-on-one investor meetings at the CG 45 Annual Growth Conference being held in Boston, MA, on Tuesday, August 12 to Thursday, August 14, 2025. Investor Contact: PJ Kelleher LifeSci Advisors Investors@cervomed.com 617-430-7579 The webcast of the fireside chat wil ...